Clover Health Investments, Corp.
CLOV
$2.00
-$0.07-3.38%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 46.93% | 48.53% | 34.27% | 33.71% | 8.86% |
| Total Other Revenue | -70.79% | 98.91% | 22.55% | 14.62% | 36.91% |
| Total Revenue | 44.74% | 49.81% | 34.07% | 33.45% | 9.28% |
| Cost of Revenue | 70.13% | 69.54% | 52.20% | 33.29% | -2.69% |
| Gross Profit | -20.99% | -10.88% | -7.68% | 33.95% | 60.30% |
| SG&A Expenses | 7.03% | 7.71% | 9.88% | 5.69% | 6.62% |
| Depreciation & Amortization | 22.09% | 19.76% | 19.39% | 46.54% | -48.96% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 49.84% | 52.87% | 40.04% | 25.55% | 0.03% |
| Operating Income | -129.95% | -161.47% | -237.85% | 94.42% | 57.07% |
| Income Before Tax | -129.60% | -177.48% | -247.53% | 94.50% | 68.38% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -129.60% | -177.48% | -247.53% | 94.50% | 68.38% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | 75.82% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -123.25% | -166.27% | -242.79% | 93.35% | 68.65% |
| EBIT | -129.95% | -161.47% | -237.85% | 94.42% | 57.07% |
| EBITDA | -131.70% | -166.82% | -227.22% | 96.41% | 57.18% |
| EPS Basic | -112.47% | -154.01% | -236.84% | 93.40% | 69.31% |
| Normalized Basic EPS | -118.32% | -149.58% | -232.65% | 94.54% | 58.00% |
| EPS Diluted | -112.47% | -154.01% | -298.10% | 93.40% | 69.31% |
| Normalized Diluted EPS | -118.32% | -149.58% | -235.42% | 94.54% | 58.00% |
| Average Basic Shares Outstanding | 5.16% | 4.60% | 4.42% | 2.20% | 2.13% |
| Average Diluted Shares Outstanding | 5.16% | 4.60% | 2.80% | 2.20% | 2.13% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |